The Hughes Report
A new era of market intelligence, rooted in the deep-dive expertise our readers trust.
About This Column
Known for his ability to translate complex technical shifts into actionable business intelligence, Anthony Hughes steps into the role previously held by George Millen. While Hughes maintains the deep analysis and well-grounded opinion that defined Millen’s Cybersecurity Edge, he brings a fresh, expansive lens to the beat. He investigates how the "security-first" mindset has evolved into a core driver of corporate strategy and market performance. This column remains committed to the rigorous standards set by his predecessor while exploring the diverse forces - from AI governance to geopolitical shifts - reshaping the modern enterprise.
Displaying items 21-40 of 766 in total
Ex-Amazon Exec Tapped to Lead Linux Foundation's AI Payment Standard
The Cell-Free Shift: EVerZom Clears Preclinical Hurdle for Crohn's Therapy
The 'Dr. Google' Dilemma: Why Pet Owners Bypass Vets for Supplements
Securing the Biopharma Supply Chain: Inside a €2 Billion Manufacturing Bet
How DARPA and MagLev Aero Are Rewriting the Physics of Drone Propulsion
The Centenarian Who Engineered Compassion: Albert O. Horner's Legacy in Modern Financial Wellness
The Anatomy of a Mega-Port: How Houston's Expansion Shapes Our Future
The Business of Calm: How Enterprise AV is Curing Smart Home Distraction
Deconstructing the Legal Architecture of Hockey's Reckoning
The Economics of Healing: Camp Boggy Creek's 30-Year Zero-Revenue Medical Model
Beyond the Silicon Monolith: How MindWalk's AMD-Powered OpenFold3 Deployment is Rewiring Pharma AI
McDermott's $1B Refinancing Restores Bonding Power and Global EPC Growth
EPIC's Detroit Play: Acquiring 113-Year-Old Korotkin Insurance Group
How Raspberry AI Is Rewriting the Economics of Fashion Retail
Uplink Launches to Solve AI’s Crippling Credential-Liability Problem
MapUp's NavGuru Blurs the Line Between Plan and Pavement
Natus' China Gambit: Why Local Manufacturing Is the New Market Entry
Beyond the Oncogene: TOLREMO's New Weapon Against Drug-Resistant Cancer
The New Playbook: Athletes Race to Own Their Digital Twins in AI Era
